p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma.

Cancer - 1 Jul 1998

Ribeiro U, Finkelstein S D, Safatle-Ribeiro A V, Landreneau R J, Clarke M R, Bakker A, Swalsky P A, Gooding W E, Posner M C

Abstract excerpt

BACKGROUND: The ability to predict biologic behavior and treatment responsiveness would be a valuable asset in the multimodality approach to esophageal carcinoma. The authors examined whether alterations of the p53 gene correlate with clinicopathologic parameters, response to preoperative chemoth...

Topics

Adult
Aged
Esophageal Neoplasms
Female
Genes, p53
Genotype
Humans
Immunohistochemistry
Male
Middle Aged
Point Mutation
Prognosis
Treatment Outcome
Tumor Suppressor Protein p53

Source

Open in PubMed

Identifiers

PMID: 9655287

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-9655287-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics